Pharmaceutical Business review

Qualitas, Valicor partner to commercialize algae-based omega-3 supplements

The companies collaborated to integrate expertise in biology, advanced chemistry and technology commercialization for algae based products.

Qualitas Health CTO Dr. Isaac Berzin said, "Exclusive access to Valicor’s extraction technology gives us a significant technological advantage and reduces the time-to-market of our pure-EPA omega-3 oil from algae."

Qualitas develops vegetarian food supplements and pharmaceutical ingredients based on microalgae.

Valicor business development VP Dr. Brian Goodall said, "The collaboration between Qualitas and Valicor brings together best-in-class cultivation and strain technology with best-in-class class extraction technology, protected by robust patents."